Background Cancer survivors—people living with and beyond cancer—are a growing
population with different health needs depending on prognosis and time since diagnosis …

Pancreatic cancer (PC) would become the second leading cause of cancer death in the near
future, despite representing only 3% of new cancer diagnosis. Survival improvement will …

Résumé Introduction L'incidence, la mortalité, la survie et la prévalence sont des indicateurs
épidémiologiques fondamentaux pour évaluer les politiques de santé publique et estimer …

Background Incidence rates of thyroid cancer (TC) increased in several countries during the
last 30 years, while mortality rates remained unchanged, raising important questions for …

Background Estimates of cancer prevalence are widely based on limited duration, often
including patients living after a cancer diagnosis made in the previous 5 years and less …

People alive many years after breast (BC) or colorectal cancer (CRC) diagnoses are
increasing. This paper aimed to estimate the indicators of cancer cure and complete …

A multidisciplinary panel of experts and cancer patients developed a position paper to
highlight recent evidence on “cancer cure”(ie, the possibility of achieving the same life …

Objectives: The goal of evidence-based practice guidelines is to optimize the management
of emerging diseases, such as differentiated thyroid cancer (DTC). The aim of this study was …

Objectives To describe the procedures to derive complete prevalence and several indicators
of cancer cure from population-based cancer registries. Materials and methods Cancer …

Background/Aim: Colorectal Cancer is the fourth most frequent cause of cancer death
worldwide and its incidence increases from 50 years of age. It is often associated with …